Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 23372002)

1.

Cancer. Cancer cell phenotypes, in fifty shades of grey.

Marusyk A, Polyak K.

Science. 2013 Feb 1;339(6119):528-9. doi: 10.1126/science.1234415. No abstract available.

PMID:
23372002
2.

Intratumor heterogeneity: finding the needle in a haystack for cancer treatment.

Camps J, Ried T, Castells A.

Gastroenterology. 2013 Jul;145(1):242-4. doi: 10.1053/j.gastro.2013.05.031. Epub 2013 May 29. No abstract available.

PMID:
23726878
3.

Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer.

Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F, Brown AM, Ng K, Ma J, Wienholds E, Dunant C, Pollett A, Gallinger S, McPherson J, Mullighan CG, Shibata D, Dick JE.

Science. 2013 Feb 1;339(6119):543-8. doi: 10.1126/science.1227670. Epub 2012 Dec 13.

4.

Tumor heterogeneity and response to chemotherapy.

Sugino S, Janicki PK.

Pharmacogenomics. 2013 Dec;14(16):1949. doi: 10.2217/pgs.13.175. No abstract available.

PMID:
24279849
5.

Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells.

Baehs S, Herbst A, Thieme SE, Perschl C, Behrens A, Scheel S, Jung A, Brabletz T, Göke B, Blum H, Kolligs FT.

Cancer Lett. 2009 Apr 18;276(2):152-9. doi: 10.1016/j.canlet.2008.11.003. Epub 2008 Dec 6.

PMID:
19059704
6.

SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells.

Zhang Y, Huang S, Dong W, Li L, Feng Y, Pan L, Han Z, Wang X, Ren G, Su D, Huang B, Lu J.

Cancer Lett. 2009 May 8;277(1):29-37. doi: 10.1016/j.canlet.2008.11.014. Epub 2008 Dec 23.

PMID:
19108950
8.

TFAP2E-DKK4 and chemoresistance in colorectal cancer.

Ebert MP, Tänzer M, Balluff B, Burgermeister E, Kretzschmar AK, Hughes DJ, Tetzner R, Lofton-Day C, Rosenberg R, Reinacher-Schick AC, Schulmann K, Tannapfel A, Hofheinz R, Röcken C, Keller G, Langer R, Specht K, Porschen R, Stöhlmacher-Williams J, Schuster T, Ströbel P, Schmid RM.

N Engl J Med. 2012 Jan 5;366(1):44-53. doi: 10.1056/NEJMoa1009473.

9.

Stem cells as common ancestors in a colorectal cancer ancestral tree.

Shibata D.

Curr Opin Gastroenterol. 2008 Jan;24(1):59-63. Review.

PMID:
18043234
10.

Pragmatic classification of superficial neoplastic colorectal lesions.

Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G.

Gastrointest Endosc. 2009 Dec;70(6):1182-99. doi: 10.1016/j.gie.2009.09.015. Epub 2009 Oct 31. No abstract available.

PMID:
19879563
11.

Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis.

Lee JH, Kang MJ, Han HY, Lee MG, Jeong SI, Ryu BK, Ha TK, Her NG, Han J, Park SJ, Lee KY, Kim HJ, Chi SG.

Clin Cancer Res. 2011 Dec 15;17(24):7551-62. doi: 10.1158/1078-0432.CCR-11-1026. Epub 2011 Oct 6.

13.

Rapid proliferation of daughter cells lacking particular chromosomes due to multipolar mitosis promotes clonal evolution in colorectal cancer cells.

Yang C, Shi X, Huang Y, Zhang Z, Cooke HJ, Wang M, Shi Q.

Cell Cycle. 2012 Jul 15;11(14):2650-9. doi: 10.4161/cc.20976. Epub 2012 Jul 15.

PMID:
22732493
14.

TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.

Costantino E, Maddalena F, Calise S, Piscazzi A, Tirino V, Fersini A, Ambrosi A, Neri V, Esposito F, Landriscina M.

Cancer Lett. 2009 Jun 28;279(1):39-46. doi: 10.1016/j.canlet.2009.01.018. Epub 2009 Feb 12.

PMID:
19217207
15.

Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.

Crea F, Nobili S, Paolicchi E, Perrone G, Napoli C, Landini I, Danesi R, Mini E.

Drug Resist Updat. 2011 Dec;14(6):280-96. doi: 10.1016/j.drup.2011.08.001. Epub 2011 Sep 28. Review.

PMID:
21955833
16.

Clinical utility of gene microarray for the management of colorectal cancer.

D'Orazio A.

Clin Colorectal Cancer. 2006 May;6(1):25-8. No abstract available.

PMID:
16796787
17.

Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.

Sanchez JA, Krumroy L, Plummer S, Aung P, Merkulova A, Skacel M, DeJulius KL, Manilich E, Church JM, Casey G, Kalady MF.

Br J Surg. 2009 Oct;96(10):1196-204. doi: 10.1002/bjs.6683.

PMID:
19787768
18.

Biology of germ cell tumors.

Ma YT, Cullen MH, Hussain SA.

Hematol Oncol Clin North Am. 2011 Jun;25(3):457-71, vii. doi: 10.1016/j.hoc.2011.03.004. Epub 2011 Apr 13. Review.

PMID:
21570602
19.

The challenges posed by cancer heterogeneity.

Bhatia S, Frangioni JV, Hoffman RM, Iafrate AJ, Polyak K.

Nat Biotechnol. 2012 Jul 10;30(7):604-10. doi: 10.1038/nbt.2294. No abstract available.

PMID:
22781679
20.

Resistance, epigenetics and the cancer ecosystem.

Baylin SB.

Nat Med. 2011 Mar;17(3):288-9. doi: 10.1038/nm0311-288. No abstract available.

PMID:
21383739
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk